TAF1 bromodomain inhibition as a candidate epigenetic driver of congenital heart disease
Open Access
- 21 March 2023
- journal article
- research article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Vol. 1869 (5) , 166689
Abstract
No abstract availableKeywords
Funding Information
- Sydäntutkimussäätiö
- Research Council of Finland (2666621)
- Sigrid Juséliuksen Säätiö
- Business Finland
- Suomen Kulttuurirahasto
- Jane ja Aatos Erkon Säätiö
This publication has 75 references indexed in Scilit:
- Control of Embryonic Stem Cell Lineage Commitment by Core Promoter Factor, TAF3Cell, 2011
- Selective inhibition of BET bromodomainsNature, 2010
- Hopx and Hdac2 Interact to Modulate Gata4 Acetylation and Embryonic Cardiac Myocyte ProliferationDevelopmental Cell, 2010
- Unexpected roles for core promoter recognition factors in cell-type-specific transcription and gene regulationNature Reviews Genetics, 2010
- Multiple faces of the SAGA complexCurrent Opinion in Cell Biology, 2010
- edgeR: a Bioconductor package for differential expression analysis of digital gene expression dataBioinformatics, 2009
- Switching of the core transcription machinery during myogenesisGenes & Development, 2007
- Regulation of HDAC9 Gene Expression by MEF2 Establishes a Negative-Feedback Loop in the Transcriptional Circuitry of Muscle DifferentiationMolecular and Cellular Biology, 2007
- GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5Nature, 2003
- Requirement of Tissue-Selective TBP-Associated Factor TAF II 105 in Ovarian DevelopmentScience, 2001